|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's Range||8.62 - 8.89|
|52 Week Range||3.97 - 19.87|
|PE Ratio (TTM)||56.56|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
If the over-allotment of stock is purchased, it'll represent a nearly $200 million cash raise.
LEAMINGTON, ON , June 15, 2018 /CNW/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APH and US OTC: APHQF) today announced the appointment of Joel Toguri as Vice President of Sales effective on June 18, 2018 . Mr. Toguri joins the Company from Southern Glazer's of Canada ("Southern Glazer's"), where he was Vice President of Sales and Operations since 2013.
Don't worry that most marijuana stocks fell after the big Canadian Senate vote on Thursday. These three stocks should be winners over the long run.
Vic Neufeld , CEO of Aphria, said, "Today's passage of Bill C-45 through the Senate is a historic milestone towards safe and legal recreational cannabis in Canada . "While we share the government's goal to create a highly regulated market, we want to ensure that the cannabis industry is well positioned to responsibly meet the needs of Canadians and effectively compete with the black market, which is operating and marketing unbound by ethical or regulatory considerations.
Unlike its southern neighbor, Canada legalized medical marijuana nationwide back in 2001. Further, Canada introduced the Cannabis Act recently and the bill to legalize recreational pot use is expected to pass by July of 2018. Not so in the U.S., where the immediate future for legal weed is in question, after Attorney General Jeff Sessions overturned an Obama-era law that protected states choosing to liberalize legal marijuana laws.
LEAMINGTON, ON , June 6, 2018 /CNW/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APH and US OTC: APHQF) today announced that the company's Board of Directors approved a $55 million capital project to build a state-of-the-art Extraction Centre of Excellence in Leamington, ON . Construction of the new Extraction Centre of Excellence is expected to begin immediately and the facility is scheduled to release its first concentrates by March 2019 . Vic Neufeld , CEO of Aphria, said, "The Extraction Centre of Excellence will give Aphria a significant competitive advantage in cannabis concentrates, which are expected to be a significant product category.
Similar to what we saw in the previous part of this series, the forward EV-to-EBITDA multiple takes into account the estimates for analysts’ one-year forward EBITDA estimates. Let’s see how this multiple has changed in the past two weeks.
As Canada prepares to fully legalize recreational marijuana, several companies are harnessing the tremendous power of technology to completely transform the entire industry, earning millions in the process
A consolidation wave is sweeping across the marijuana industry, as companies aim to improve their competitive positioning and market share in an industry which offers a lot a promise. Aurora Cannabis Inc (OTC: ACBFF) recently announced a deal to buy MedReleaf Corp (OTC: MEDFF) in an all-cash transaction valued at C$3.2 billion. The proposed combination would mean a total funded capacity of over 570,000 kg per year of high-quality facilities in Canada and Denmark.
The Venture will focus on expanding the Company's footprint in established regulated cannabis markets in Africa . LEAMINGTON, ON , May 28, 2018 /CNW/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APH and US OTC: APHQF) today announced that it has entered into a series of agreements (the "Transaction") resulting in Aphria forming a joint venture, CannInvest Africa Ltd. ("CannInvest"), with South African company Verve Group of Companies ("VGC").
The Scotts Miracle-Gro Company (SMG) received a recent upgrade from a “buy” to a “hold” from SunTrust Robinson Humphrey. The firm also raised its price target to $100 from $80, saying that the stock will likely see an upside when the hydroponics business takes off on the back of increased cannabis use. The stock had terrible first and second quarter results, and the stock is now 19.5% lower YTD (year-to-date) as of May 16.
Last week, the cannabis sector was broadly positive with the ETF Horizons Marijuana Life Sciences ETF (HMMJ) rising ~4.3%, the Evolve Marijuana ETD (SEED) rising 3%, the ETFMG Alternative Harvest ETF (MJ) rising 1.3%, and the Emerging Marijuana Growers Index ETF (HMJR) rising 0.4% between the close on May 11 and the close on May 18. Over the same period, the TSE 300 Index gained about 1.1%, while the S&P 500 Index fell 0.5%. Let’s look at how some of the cannabis stocks performed last week.
On May 16, CannTrust (CNTTF) dropped almost 8.3% on news of further dilution of the stock. The company announced an upsizing of its previously announced offering in which the company will grant its underwriters, Canaccord Genuity and GMP Securities, the option to purchase an additional 1.5 million shares at a price of 9 Canadian dollars. The stock has delivered a loss of 3.2% YTD (year-to-date) but has performed better than industry stocks (MJ) like Aphria (APHQF) and Aurora Cannabis (ACB) (ACBFF).
Aphria (APHQF) is also doing its part to penetrate markets where medical cannabis (SEED-TSE) is legal. On May 16, the company signed an exclusive agreement to supply medical cannabis in Columbia. The agreement is with Colcanna SAS, which has the license to import and distribute medical cannabis in the country.
Cronos Group (CRON) reported its first-quarter earnings on May 15 with sales growth of almost 4.8x. Following the earnings release, the stock fell 5% on May 15 and fell another 3.4% on May 16 to 7.7 Canadian dollars. The company cut its recommendation to “sell” from “hold” but raised the price target to 6.5 Canadian dollars from 6 Canadian dollars.
LEAMINGTON, ON , May 17, 2018 /CNW/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APH and US OTC: APHQF) today announced that its wholly-owned subsidiary Nuuvera Deutschland GmbH ("Deutschland") has acquired a 25.1% interest in Berlin -based Schöneberg Hospital ("Schöneberg" or the "Hospital"). The acquisition facilitates Deutschland's long-term strategy to educate German physicians and patients and advance evidence that supports the effectiveness of medical cannabinoids.
LEAMINGTON , ON and TORONTO , May 17, 2018 /CNW/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APH and US OTC: APHQF) and Great North Distributors, Inc. ("Great North Distributors"), a wholly-owned Canadian subsidiary of Southern Glazer's Wine & Spirits ("Southern Glazer's") dedicated to the representation of cannabis products, are pleased to announce today that they have signed an agreement for Great North Distributors to serve as exclusive manufacturer's representative for Aphria's adult-use cannabis products throughout Canada , following the legalization of recreational cannabis for adult-use anticipated later this year.
Aphria Inc. (“Aphria” or the “Company”) (TSX: APH and US OTC: APHQF) and Great North Distributors, Inc. (“Great North Distributors”), a wholly-owned Canadian subsidiary of Southern Glazer’s Wine & Spirits (“Southern Glazer’s”) dedicated to the representation of cannabis products, are pleased to announce today that they have signed an agreement for Great North Distributors to serve as exclusive manufacturer’s representative for Aphria’s adult-use cannabis products throughout Canada, following the legalization of recreational cannabis for adult-use anticipated later this year.
LEAMINGTON , ON, May 16, 2018 /CNW/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APH and US OTC: APHQF) today announced that it has signed an exclusive supply agreement with Colcanna SAS ("Colcanna") a Colombia -based pharmaceutical import and distribution company, which is licensed to import, sell and distribute medical cannabis, medical products and derivatives in Colombia . "We see tremendous potential for medical cannabis in several emerging markets, including Colombia ," said Vic Neufeld , CEO of Aphria.
Cronos Group (CRON) reported its first-quarter earnings on May 15. The company’s sales rose almost 4.8 times year-over-year to 2.9 million Canadian dollars from 0.5 million Canadian dollars in the first quarter of 2017. Sequentially, sales grew 83% from 1.3 million Canadian dollars.